Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

About this update from Collegium Pharmaceutical, Inc.

STOUGHTON, Mass. , April 24, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report first quarter 2025 financial results after the market closes on Thursday, May 8, 2025. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET. Conference Call Information To access the conference call, please dial (877) 407-8037 ( U.S. ) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q1 2025 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com . The webcast will be available for replay on the Company’s website approximately two hours after the event. About Collegium Pharmaceutical, Inc. Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and recently acquired Jornay PM, a treatment for ADHD, establishing a presence in neuropsychiatry. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts . For more information, please visit the Company’s website at www.collegiumpharma.com . Investor Contacts: Ian Karp Head of Investor Relations [email protected] Danielle Jesse Director, Investor Relations [email protected] Media Contact: Cheryl Wheeler Head of Corporate Communications [email protected] Source: Collegium Pharmaceutical, Inc.

View stock analysis, news, and events for Collegium Pharmaceutical, Inc.